1. Home
  2. MO vs VRTX Comparison

MO vs VRTX Comparison

Compare MO & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MO
  • VRTX
  • Stock Information
  • Founded
  • MO 1822
  • VRTX 1989
  • Country
  • MO United States
  • VRTX United States
  • Employees
  • MO N/A
  • VRTX N/A
  • Industry
  • MO Medicinal Chemicals and Botanical Products
  • VRTX EDP Services
  • Sector
  • MO Health Care
  • VRTX Technology
  • Exchange
  • MO Nasdaq
  • VRTX Nasdaq
  • Market Cap
  • MO 90.9B
  • VRTX 104.8B
  • IPO Year
  • MO N/A
  • VRTX 1991
  • Fundamental
  • Price
  • MO $59.27
  • VRTX $482.33
  • Analyst Decision
  • MO Buy
  • VRTX Buy
  • Analyst Count
  • MO 7
  • VRTX 25
  • Target Price
  • MO $53.29
  • VRTX $505.61
  • AVG Volume (30 Days)
  • MO 11.4M
  • VRTX 1.3M
  • Earning Date
  • MO 04-29-2025
  • VRTX 05-05-2025
  • Dividend Yield
  • MO 7.02%
  • VRTX N/A
  • EPS Growth
  • MO 43.25
  • VRTX N/A
  • EPS
  • MO 6.54
  • VRTX N/A
  • Revenue
  • MO $20,444,000,000.00
  • VRTX $11,020,100,000.00
  • Revenue This Year
  • MO $2.43
  • VRTX $10.64
  • Revenue Next Year
  • MO $0.37
  • VRTX $9.01
  • P/E Ratio
  • MO $8.89
  • VRTX N/A
  • Revenue Growth
  • MO N/A
  • VRTX 11.66
  • 52 Week Low
  • MO $40.65
  • VRTX $377.85
  • 52 Week High
  • MO $59.67
  • VRTX $519.88
  • Technical
  • Relative Strength Index (RSI)
  • MO 64.39
  • VRTX 43.50
  • Support Level
  • MO $57.76
  • VRTX $497.78
  • Resistance Level
  • MO $59.32
  • VRTX $513.98
  • Average True Range (ATR)
  • MO 0.82
  • VRTX 12.52
  • MACD
  • MO -0.09
  • VRTX -3.72
  • Stochastic Oscillator
  • MO 89.60
  • VRTX 22.48

About MO Altria Group Inc.

Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2023. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev, a 42% stake in cannabis manufacturer Cronos, acquired Njoy Holdings in 2023, and operates a joint venture with Japan Tobacco in the heated tobacco category. It also recently disposed of its investment in Juul Labs.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: